JPH203 - Moligand™, ≥97% , Inhibitor of L-type amino acid transporter 1, CAS No.1037592-40-7, Inhibitor of L-type amino acid transporter 1

CAS: 1037592-40-7 Cat. No.: J414105 Summenformel: C23H19Cl2N3O4 Molekulargewicht: 472.32
Zu bestellen verfügbar
QUALITÄT & REINHEIT Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥97%
Synonyms
JPH203 free base|(2S)-2-amino-3-[4-[(5-amino-2-phenyl-1,3-benzoxazol-7-yl)methoxy]-3,5-dichlorophenyl]propanoic acid|JPH203|JPH-203|L-Tyrosine, O-((5-amino-2-phenyl-7-benzoxazolyl)methyl)-3,5-dichloro-|(S)-2-amino-3-(4-((5-amino-2-phenylbenzo[d]oxazol-7-yl)methoxy)-3,5-dichlorophenyl)propanoic acid|1-ethyl-4-(2-propan-2-ylidenehydrazinyl)-5-pyrazolo[3,4-b]pyridinecarboxylic acid ethyl ester|(2S)-2-Amino-3-(4-((5-amino-2-phenyl-1,3-benzoxazol-7-yl)methoxy)-3,5-dichloro-phenyl)propanoic acid|(s)-2-amino-3-(4-((5-amino-2-phenylbenzo[d]oxazol-7-yl)methoxy)-3,5-dichlorophenyl) propanoic acid|NANVURANLAT [INN]|ETHENZAMIDE [MART.]|NANVURANLAT|O-[(5-Amino-2-phenyl-7-benzoxazolyl)methyl]-3,5-dichloro-L-tyrosine|O-((5-AMINO-2-PHENYL-1,3-BENZOXAZOL-7-YL)METHYL)-3,5- DICHLORO-L-TYROSINE|L-Tyrosine, O-[(5-amino-2-phenyl-7-benzoxazolyl)methyl]-3,5-dichloro-;L-Tyrosine, O-[(5-amino-2-phenyl-7-benzoxazolyl)methyl]-3,5-dichloro-|COMPOUND-JP [US20160279103]|CEDO9QXYZK
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Größe
Deutschland (EU)
USA*
Preis
Menge
5mg
J414105-5mg
—
2 Auf Lager

38,96€

58,92€
Speichern 19,96 € (33.87%)
10mg
J414105-10mg
—
5 Auf Lager

70,20€

105,78€
Speichern 35,58 € (33.63%)
25mg
J414105-25mg
—
1 Auf Lager

152,64€

229,00€
Speichern 76,36 € (33.35%)
50mg
J414105-50mg
—
1 Auf Lager

244,62€

366,97€
Speichern 122,35 € (33.34%)
100mg
J414105-100mg
Auf Bestellung · 8–12 Wochen

440,72€

661,13€
Speichern 220,41 € (33.34%)
Enter a quantity for the sizes you want to add.

Übersicht

Information

JPH203 JPH203 (KYT-0353, JPH-203SBECD), a selective L-type amino acid transporter 1 inhibitor, shows a dramatic inhibition of leucine uptake (IC50=0.06 µM) and cell growth (IC50=4.1 µM) in human colon cancer cells (HT-29), human oral cancer cells (YD-38) and leukemic cells.


Targets

LAT1 (Cell-free assay)


In vitro

JPH203 completely and slightly inhibited the L-Leucine uptake in YD-38 cells (IC50 value: 0.79 μM) and NHOKs (IC50 value: >100 μM), respectively. JPH203 inhibited HT-29 cell growth, generating an apparent IC50 of 4.1 μM, but the JPH203 IC50 concentration (0.06 μM) needed to inhibit the L-Leucine uptake did not inhibit HT-29 cell growth, which represents a 68-fold difference in susceptibility. JPH203 activated the mitochondria-dependent apoptotic signaling pathway by upregulating pro-apoptotic factors, such as Bad, Bax, and Bak, and the active form of caspase-9, and downregulating anti-apoptotic factors, such as Bcl-2 and Bcl-xL in Saos2 human osteosarcoma cells. JPH203 can distinguish relative abundance between LAT1 and LAT2. It has high selectivity for LAT1. JPH203 was metabolically stable in mouse, rat, dog, monkey and human liver microsomal incubations. JPH203 induces both G2/M and G0/G1 cell cycle arrest, as well as reduced the S phase accompanied by altered expression of the proteins in cell cycle progression: cyclin D1, CDK4, and CDK6.


In vivo

Daily intravenous administration of JPH203 (12.5 and 25 mg/kg) significantly inhibited tumor growth in KKU-213 cholangiocarcinoma cell xenografts in the nude mice model in a dose-dependent manner with no statistically significant change in the animal’s body weight and with no differences in the histology and appearance of the internal organs compared with the control group. Thus, JPH203 shows anti-tumor efficacy in nude mice bearing human cholangiocarcinom (CCA) cell xenografts without general toxicity.


Cell Research(from reference)

Cell lines:Saos2 human osteosarcoma cells 

Concentrations:100 µM 

Incubation Time:72 h 

Spezifikationen

Synonyme
JPH203 free base | (2S)-2-amino-3-[4-[(5-amino-2-phenyl-1,3-benzoxazol-7-yl)methoxy]-3,5-dichlorophenyl]propanoic acid | JPH203 | JPH-203 | L-Tyrosine, O-((5-amino-2-phenyl-7-benzoxazolyl)methyl)-3,5-dichloro- | (S)-2-amino-3-(4-((5-amino-2-phenylbenzo[d]oxazol-7-yl)methoxy)-3,5-dichlorophenyl)propanoic acid | 1-ethyl-4-(2-propan-2-yliden Show more
Spezifikationen & Reinheit
Moligand™, ≥97%
Biochemische und physiologische Mechanismen
JPH203 (KYT-0353, JPH-203SBECD), a selective L-type amino acid transporter 1 inhibitor, shows a dramatic inhibition of leucine uptake (IC50=0.06 µM) and cell growth (IC50=4.1 µM) in human colon cancer cells (HT-29), human oral cancer cells (YD-38) and leukemic cells.
Storage
Store at -20°C
Verschickt in
Ice chest + Ice pads
Dieses Produkt erfordert Kühlkettenversand. Grundversand und andere Economy-Optionen sind nicht verfügbar.
Note
Moligand™
Aktionsart
INHIBITOR
Mechanismus der Wirkung
Inhibitor of L-type amino acid transporter 1
Reinheit
≥97%
Namen und Kennungen
Pubchem Sid
Pubchem Sid Url
https://pubchem.ncbi.nlm.nih.gov/substance/528765010
SMILES
C1=CC=C(C=C1)C2=NC3=CC(=CC(=C3O2)COC4=C(C=C(C=C4Cl)CC(C(=O)O)N)Cl)N
IUPAC Name
(2S)-2-amino-3-[4-[(5-amino-2-phenyl-1,3-benzoxazol-7-yl)methoxy]-3,5-dichlorophenyl]propanoic acid
InChIKey
XNRZJPQTMQZBCE-SFHVURJKSA-N
InChI
1S/C23H19Cl2N3O4/c24-16-6-12(8-18(27)23(29)30)7-17(25)21(16)31-11-14-9-15(26)10-19-20(14)32-22(28-19)13-4-2-1-3-5-13/h1-7,9-10,18H,8,11,26-27H2,(H,29,30)/t18-/m0/s1
Isomere SMILES
C1=CC=C(C=C1)C2=NC3=CC(=CC(=C3O2)COC4=C(C=C(C=C4Cl)C[C@@H](C(=O)O)N)Cl)N
Molekulargewicht
472.32
Reaxys
34121265
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=34121265&ln=

Erweiterte Daten

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganic acids and derivatives
KlasseCarboxylic acids and derivatives
SubclassAmino acids, peptides, and analogues
Intermediate Tree Nodes Amino acids and derivatives - Alpha amino acids and derivatives
Direct ParentPhenylalanine and derivatives
Alternative Parents Phenylpropanoic acids  Phenyl-1,3-oxazoles  L-alpha-amino acids  Amphetamines and derivatives  Benzoxazoles  Phenoxy compounds  Dichlorobenzenes  Phenol ethers  Aralkylamines  Alkyl aryl ethers  Aryl chlorides  Heteroaromatic compounds  Amino acids  Oxacyclic compounds  Azacyclic compounds  Carboxylic acids  Monocarboxylic acids and derivatives  Carbonyl compounds  Hydrocarbon derivatives  Monoalkylamines  Organic oxides  Organochlorides  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents Phenylalanine or derivatives - Phenyl-1,3-oxazole - 3-phenylpropanoic-acid - Alpha-amino acid - Amphetamine or derivatives - L-alpha-amino acid - Benzoxazole - Phenol ether - Phenoxy compound - 1,3-dichlorobenzene - Alkyl aryl ether - Aralkylamine - Chlorobenzene - Halobenzene - Benzenoid - Aryl halide - Aryl chloride - Monocyclic benzene moiety - Heteroaromatic compound - Azole - Oxazole - Amino acid - Carboxylic acid - Monocarboxylic acid or derivatives - Azacycle - Oxacycle - Ether - Organoheterocyclic compound - Organic nitrogen compound - Primary aliphatic amine - Organohalogen compound - Carbonyl group - Organochloride - Organonitrogen compound - Organooxygen compound - Primary amine - Hydrocarbon derivative - Organic oxide - Amine - Organic oxygen compound - Aromatic heteropolycyclic compound
BeschreibungThis compound belongs to the class of organic compounds known as phenylalanine and derivatives. These are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.
External Descriptors Not available
3D-Struktur
Interaktives chemisches Strukturmodell





Zugehörige Ziele (menschlich)
SLC7A5 Tchem Large neutral amino acids transporter small subunit 1 (2 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Wirkungsmechanismen
Zertifikate (CoA, COO, BSE/TSE und Analyse-Diagramm)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

13 results found

Lot NumberCertificate TypeDatumArtikel
H2520359H2520359Certificate of AnalysisSep 04, 2024 J414105
H2520372H2520372Certificate of AnalysisSep 04, 2024 J414105
H2520474H2520474Certificate of AnalysisSep 04, 2024 J414105
H2520480H2520480Certificate of AnalysisSep 04, 2024 J414105
H2520481H2520481Certificate of AnalysisSep 04, 2024 J414105
I2404546I2404546Certificate of AnalysisAug 26, 2024 J414105
I2404547I2404547Certificate of AnalysisAug 26, 2024 J414105
I2404548I2404548Certificate of AnalysisAug 26, 2024 J414105
I2404549I2404549Certificate of AnalysisAug 26, 2024 J414105
I2404550I2404550Certificate of AnalysisAug 26, 2024 J414105
I2404551I2404551Certificate of AnalysisAug 26, 2024 J414105
I2404552I2404552Certificate of AnalysisAug 26, 2024 J414105
I2404553I2404553Certificate of AnalysisAug 26, 2024 J414105
Chemische und physikalische Eigenschaften
LöslichkeitSolubility (25°C) In vitro 5%TFA 2.31 mg/mL warmed with 50ºC Water: bath (4.89 mM); DMSO: 0.01 mg/mL (0.02 mM); Water: Insoluble;
Molekulargewicht472.3
XLogP32.100
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count7
Rotatable Bond Count7
Exact Mass471.075 Da
Monoisotopic Mass471.075 Da
Topological Polar Surface Area125.000 Ų
Heavy Atom Count32
Formal Charge0
Complexity626.000
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Sicherheit und Gefahren (GHS)
Reaxys
34121265
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=34121265&ln=
Citations of This Product
Lösungsrechner
Bewertungen

Kundenbewertungen

Benötigen Sie Hilfe bei der Auswahl der Qualität?

Unser Leitfaden zur Qualitätsauswahl behandelt Reinheit, Stabilisatorstatus und Anwendungseignung für alle Varianten in unserem Katalog.

Moligand™ Qualitätsleitfaden ansehen →

Dürfen wir Sie über Rabattaktionen informieren?

Später erinnern

Vielen Dank! Bitte überprüfen Sie Ihren E-Mail-Posteingang, um zu bestätigen.

Hoppla! Benachrichtigungen sind deaktiviert.